
    
      A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative
      Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI,
      formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of
      Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative
      Pathogen in Hospitalized Adults
    
  